Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Chapter 69 Immunosuppressants Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Immunosuppressants Inhibit immune response Uses Prevention of organ rejection Treatment of autoimmune diseases Toxicity Increased risk of infection Increased risk of neoplasms Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 2 Calcineurin Inhibitors Principal use is for prevention of organ rejection in transplant recipients Cyclosporine and tacrolimus—most effective immunosuppressants available Differ in structure, but share the same mechanism Inhibition of calcineurin suppresses production of interleukin (IL)-2 IL-2 needed for T-cell proliferation Cyclosporine developed first and used more than tacrolimus Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 3 Fig. 69–1. Sites of action of immunosuppressant drugs. Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 4 Cyclosporine (Sandimmune) Mechanism Therapeutic uses Suppresses the production of interleukin-2, interferon gamma, and other cytokines Drug of choice for organ rejection (kidney, liver, and heart) of an allogenic transplant Some autoimmune diseases Pharmacokinetics Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 5 Cyclosporine (Sandimmune) Adverse effects Nephrotoxicity Infection Hepatotoxicity Lymphoma Hypertension Tremor Hirsutism Leukopenia, gingival hyperplasia, gynecomastia, sinusitis, hyperkalemia Anaphylactic reactions Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 6 Cyclosporine (Sandimmune) Drug and food interactions Drugs that can decrease cyclosporine levels Drugs that can increase cyclosporine levels Nephrotoxic drugs Grapefruit juice Repaglinide Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 7 Tacrolimus (Prograf) An alternative to cyclosporine Somewhat more effective—but also more toxic Concurrent use with glucocorticoids Therapeutic use Prophylaxis of organ rejection (liver, kidney, or heart) Mechanism of action Adverse effects Nephrotoxicity is the major concern Neurotoxicity GI effects Hypertension Hyperkalemia Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 8 Tacrolimus (Prograf) Adverse effects (cont’d) Hyperglycemia Hirsutism Gum hyperplasia Anaphylaxis with IV administration Drug and food interactions Agents that inhibit CYP3A (an isozyme of cytochrome P450) Grapefruit juice NSAIDs should be avoided Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 9 mTOR Inhibitors Enzyme known as mammalian target of rapamycin (mTOR) Protein kinase that helps regulate cell growth, proliferation, and survival Structurally similar to tacrolimus Somewhat different mechanism Does not involve inhibition of calcineurin Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 10 Sirolimus (Rapamune) Actions and therapeutic use Only for prevention of renal transplant rejection Used in conjunction with cyclosporine and glucocorticoids Adverse effects Increased risk of infection Raises levels of cholesterol and triglycerides Risk of renal injury Severe complications in the liver and lung Rash, acne, anemia, thrombocytopenia, joint pain, diarrhea, hypokalemia Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 11 Sirolimus (Rapamune) Drug and food interactions Drugs that inhibit or induce CYP3A4 (the 3A4 isozyme of cytochrome P450) High-fat foods Grapefruit juice Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 12 Everolimus (Zortress) Therapeutic use Mechanism of action Adverse effects Peripheral edema (45%) Constipation (38%) Hypertension (30%) Nausea (29%) Anemia (26%) Urinary tract infection (22%) Hyperlipidemia (21%) Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 13 Everolimus (Zortress) Effects in pregnancy and lactation Drug and food interactions Drugs that inhibit or induce CYP3A4 (the 3A4 isozyme of cytochrome P450) High-fat foods Grapefruit juice Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 14 Glucocorticoids Used to widely suppress immune response Suppression of allograft rejection, treatment of asthma, rheumatoid arthritis, systemic lupus erythematosus (SLE), and multiple sclerosis Large doses used to prevent rejection Increased risk of infection, thinning of skin, bone dissolution with fracture, impaired growth in children, and suppression of hypothalamicpituitary-adrenal axis Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 15 Cytotoxic Drugs Suppress immune response by killing B and T lymphocytes undergoing proliferation Nonspecific—toxic to all proliferating cells Adverse effects Bone marrow suppression • Neutropenia • Thrombocytopenia GI disturbances Reduced fertility Alopecia Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 16 Cytotoxic Drugs Azathioprine (Imuran) Therapeutic uses Suppresses cell-mediated and humoral immune responses Adjuvant treatment with transplants Autoimmune disorders Adverse effects Neutropenia Thrombocytopenia Mutagenic and teratogenic Neoplasms Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 17 Other Cytotoxic Drugs Cyclophosphamide (Cytoxan, Neosar) Methotrexate (Rheumatrex, Trexall) Anticancer drug Anticancer agent Autoimmune disorders Suppression of B and T lymphocytes Mitoxantrone (Novantrone) Anticancer agent Reduction of neurologic disability and clinical relapse for multiple sclerosis (MS) patients Dangerous drug reserved for patients who are not responsive to safer drugs Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 18 Other Cytotoxic Drugs Mycophenolate mofetil (CellCept, Myfortic) Approved for prophylaxis of organ rejection Acts on B and T lymphocytes to inhibit inosine monophosphate dehydrogenase Selective inhibition of B- and T-lymphocyte proliferation Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 19 Antibodies Muromonab-CD3 (Orthoclone OKT3) Actions and uses Monoclonal antibody Blocks all T-cell function Prevents acute rejection of transplants Depletes T cells before bone marrow transplant Adverse effects Fever Chills Dyspnea Chest pain Nausea and vomiting Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 20 Other Antibodies Basiliximab Monoclonal antibodies Blocks activation of T cells by IL-2 Prophylaxis of acute organ rejection Lymphocyte immune globulin (Atgam) Antithymocyte (Equine) Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 21